Economic evaluations of whole-genome sequencing for pathogen identification in public health surveillance and health-care-associated infections: a systematic review

    Research output: Contribution to journalReview articlepeer-review

    9 Citations (Scopus)

    Abstract

    Whole-genome sequencing (WGS) has resulted in improvements to pathogen characterisation for the rapid investigation and management of disease outbreaks and surveillance. We conducted a systematic review to synthesise the economic evidence of WGS implementation for pathogen identification and surveillance. Of the 2285 unique publications identified through online database searches, 19 studies met the inclusion criteria. The economic evidence to support the broader application of WGS as a front-line pathogen characterisation and surveillance tool is insufficient and of low quality. WGS has been evaluated in various clinical settings, but these evaluations are predominantly investigations of a single pathogen. There are also considerable variations in the evaluation approach. Economic evaluations of costs, effectiveness, and cost-effectiveness are needed to support the implementation of WGS in public health settings.

    Original languageEnglish
    Pages (from-to)e953-e962
    JournalThe Lancet Microbe
    Volume4
    Issue number11
    DOIs
    Publication statusPublished - Nov 2023

    Fingerprint

    Dive into the research topics of 'Economic evaluations of whole-genome sequencing for pathogen identification in public health surveillance and health-care-associated infections: a systematic review'. Together they form a unique fingerprint.

    Cite this